OQS
TBI

Occudo Quantitative Strategies’s Trueblue TBI Stock Holding History

Occudo Quantitative Strategies’s Portfolio TBI Stock Details TBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,601
Closed -$61.9K – 918
2025
Q4 		$61.9K Sell
13,601
-829
-6% -$4.25K ﹤0.01% 662
2025
Q3 		$88.5K Sell
14,430
-12,280
-46% -$77.7K 0.01% 628
2025
Q2 		$173K Buy
26,710
+4,618
+21% +$24.9K 0.02% 545
2025
Q1 		$123K Buy
+22,092
New +$151K 0.02% 593
2024
Q3 		– Sell
-14,479
Closed -$149K – 1009
2024
Q2 		$149K Sell
14,479
-21,938
-60% -$238K 0.03% 628
2024
Q1 		$456K Buy
+36,417
New +$471K 0.08% 328
2023
Q4 		– Sell
-36,765
Closed -$539K – 1185
2023
Q3 		$539K Buy
36,765
+26,150
+246% +$407K 0.07% 463
2023
Q2 		$188K Buy
+10,615
New +$180K 0.02% 860
2023
Q1 		– Sell
-15,394
Closed -$301K – 1193
2022
Q4 		$301K Buy
+15,394
New +$312K 0.04% 660

Other funds holding TBI

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Occudo Quantitative Strategies's TBI Position: Q1 2026 in Review

Occudo Quantitative Strategies sold out of Trueblue (TBI) in Q1 2026, closing a stake of 13,601 shares — an estimated $61.9K sold.

Occudo Quantitative Strategies first reported a position in TBI in Q4 2022 and held it in 9 quarters. The position peaked at $539K in Q3 2023. 105 funds tracked by Wall St. Rank hold TBI as of Q1 2026.

  • Occudo Quantitative Strategies reported no remaining Trueblue position as of Q1 2026 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 13,601 Trueblue shares in Q1 2026, an estimated $61.9K.
  • Occudo Quantitative Strategies first reported a position in Trueblue in Q4 2022 and held it in 9 quarters.
  • Occudo Quantitative Strategies's Trueblue position peaked at $539K in Q3 2023.
  • 105 funds tracked by Wall St. Rank held Trueblue as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.